Cencora, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
COR
Cencora, INCCencora, Inc. announced robust financial results for fiscal year 2025, driven by significant revenue growth in U.S. Healthcare Solutions and strategic acquisitions, despite a goodwill impairment charge.
NYSE
COR
Cencora, INCCencora, Inc. reports a 12.1% increase in revenue for fiscal year 2024, driven by growth in U.S. Healthcare Solutions, and announces the acquisition of Retina Consultants of America for approximately $4.6 billion.